European Archives - Page 326 of 1053 - European Medical Journal

Urticaria and Beyond

Honing in on urticaria and other mast cell driven diseases, experts at the EAACI Congress 2023 presented a forward-thinking session in one of the most insightful symposia from the hybrid meeting hosted in Hamburg, Germany.

Putting Guidelines into Practice: Supporting Young People with Hereditary Angioedema to Live Attack-Free

The availability of specific licensed medicines to treat acute HAE attacks and prophylactic options to prevent future episodes is changing the way people with HAE are treated, and is giving them hope for a future free from debilitating HAE attacks.

Transplantation Versus Gene Therapy for Sickle Cell Disease

A captivating session, presented at EHA Congress 2023, on sickle cell disease explored the role of allogeneic stem cell transplantation in this condition, as well as gene therapy and gene editing in treating patients with SCD.

Targeted Therapeutics in CLL and MCL

Targeted Therapeutics in CLL and MCL. Applying Emerging BTK Inhibitor Therapy Data to Practice. This infographic was supported by educational grant from Lilly.

AIT Clinical Relevance: Patients' Benefits All Along the Treatment Journey

This infographic explores the clinical relevance of allergen immunotherapies asthma, hay fever and rhinitis, and the patient benefits observed.

Introducing the Concept of Patient Blood Management and Haemovigilance in Government Sector Hospitals of Sindh, Pakistan

Patient blood management encompasses all aspects of the transfusion decision-making process, beginning with the initial patient evaluation and continuing through clinical management.

EAACI Guidelines on Diagnosis of Food Allergy: What Is New?

An engaging session presenting the newly-revised European Academy of Allergy and Clinical Immunology guidelines on the diagnosis of food allergy, centred around the accuracy of diagnostic tests and recommendations for practice.

Steroid Toxicity in Immune Thrombocytopaenia

This article summarises the occurrence of very unusual and rare steroid-related toxicity. It is a cautionary tale of modern medicine where the treatment-related adverse events are more atrocious than the primary disease.

Immunotherapy, Targeted Therapy, and Novel Approaches to Treating Lymphoma

Lymphoma experts presented an insightful exploration of clinical trial data on immunotherapy and targeted therapeutics for diffuse large B-cell lymphoma, follicular lymphoma, and mantle cell lymphoma.

Editor’s Pick: Drug-Induced Thrombocytopenic Purpura

In the present systematic review and meta-analysis, the authors analysed case reports of drug-induced thrombocytopenia/drug-induced…